US Patent 7674459 Treatment of cancer with a novel anti-IL13 monoclonal antibody
Patent 7674459 was granted and assigned to Genentech on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+317 characters)
Article
Patent abstract
The present invention relates to the treatment of IL13 dependent neoplastic disorders comprising the administration of novel anti-IL13 antibodies, The invention also includes diagnosing such tumors or cancer using the antibodies of the present invention to detect overexpression of IL13 in the patient.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07674459 Treatment of cancer with a novel anti-IL13 monoclonal antibody US Patent 7674459 Treatment of cancer with a novel anti-IL13 monoclonal antibody
Infobox
Patent Number
0767445900
Patent Number
767445900
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076744590
Date of Patent
March 9, 2010
0Patent Application Number
105839260
Date Filed
December 23, 2004
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076744590
Date of Patent
March 9, 2010
0Patent Application Number
105839260
Date Filed
December 23, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07674459 Treatment of cancer with a novel anti-IL13 monoclonal antibody
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07674459
Date of patent
March 9, 2010
Patent application number
10583926
Date Filed
December 23, 2004
Patent primary examiner
Find more entities like US Patent 7674459 Treatment of cancer with a novel anti-IL13 monoclonal antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.